康缘药业：实际控制人的一致行动人增持8万股公司股份

Group 1 - The actual controller of Kangyuan Pharmaceutical, Mr. Xiao Wei, and his associates, Mr. Xiao Lihao and Ms. Zhao Shiwen, have increased their holdings in the company by a total of 80,000 shares, representing 0.0141% of the total share capital, with an investment amount of approximately 1.25 million yuan, reflecting their confidence in the company's future development and long-term investment value [1] - As of the first half of 2025, Kangyuan Pharmaceutical's revenue composition shows that domestic sales from industrial enterprises account for 98.89%, while other business activities account for 1.11% [1] - The current market capitalization of Kangyuan Pharmaceutical is 8.8 billion yuan [2]